5. Conclusions
HIV stage
In conclusion, our cohort confirms previous data from the TANGO study. Furthermore, it demonstrates that DTG+3TC is an effective treatment strategy for virologically-suppressed PLWHIV independent of age, sex, and HIV stage, as well as a safe and durable strategy, even under the stress of the COVID-19 pandemic. In addition, a potential immunological benefit in terms of CD4+ lymphocyte count and increased CD4+/CD8+ ratio is also suggested.